Renton Hollings
Director
Sale
Calculated transaction value
$249.37K
5,000 shares @ $49.87
Traded
Oct 1, 2026
Filed
Oct 2, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AnaptysBio
ANAB
ManufacturingChemicals
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
13 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Renton Hollings Director | Oct 2, 2026 1-day lag | Sale Oct 1, 2026 | $249.37K Filed shares x price | SEC Form 4 View filing | |
| Renton Hollings Director | Oct 2, 2026 1-day lag | Exercise Oct 1, 2026 | $90.15K Filed shares x price | SEC Form 4 View filing | |
| Renton Hollings Director | Oct 2, 2026 1-day lag | Exercise Oct 1, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Orwin John A Director | Sep 17, 2026 2-day lag | Exercise Sep 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Orwin John A Director | Sep 17, 2026 2-day lag | Exercise Sep 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Lizzul Paul F. Chief Medical Officer | Aug 7, 2026 148-day lag | Award Mar 12, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Faga Daniel President, CEO | Aug 7, 2026 148-day lag | Award Mar 12, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Orwin John A Director | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Renton Hollings Director | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Schmid John P. Director | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Renton Hollings Director | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Schmid John P. Director | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Orwin John A Director | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing |
Renton Hollings
Director
Exercise
Calculated transaction value
$90.15K
5,000 shares @ $18.03
Traded
Oct 1, 2026
Filed
Oct 2, 2026
Renton Hollings
Director
Exercise
Calculated transaction value
$0
5,000 shares @ $0
Traded
Oct 1, 2026
Filed
Oct 2, 2026
Orwin John A
Director
Exercise
Calculated transaction value
$0
1,300 shares @ $0
Traded
Sep 15, 2026
Filed
Sep 17, 2026
Orwin John A
Director
Exercise
Calculated transaction value
$0
1,300 shares @ $0
Traded
Sep 15, 2026
Filed
Sep 17, 2026
Lizzul Paul F.
Chief Medical Officer
Award
Calculated transaction value
$0
16,667 shares @ $0
Traded
Mar 12, 2026
Filed
Aug 7, 2026
Faga Daniel
President, CEO
Award
Calculated transaction value
$0
53,334 shares @ $0
Traded
Mar 12, 2026
Filed
Aug 7, 2026
Orwin John A
Director
Exercise
Calculated transaction value
$0
6,030 shares @ $0
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Renton Hollings
Director
Exercise
Calculated transaction value
$0
6,030 shares @ $0
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Schmid John P.
Director
Exercise
Calculated transaction value
$0
6,030 shares @ $0
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Renton Hollings
Director
Exercise
Calculated transaction value
$0
6,030 shares @ $0
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Schmid John P.
Director
Exercise
Calculated transaction value
$0
6,030 shares @ $0
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Orwin John A
Director
Exercise
Calculated transaction value
$0
6,030 shares @ $0
Traded
Jun 15, 2026
Filed
Jun 17, 2026